Since netrin-1 derived from macrophages has a regulatory effect on pulmonary fibrosis, netrin-1 precisely targeting macrophages may become a new therapy with better efficacy than adrenergic antagonists in the treatment of IPF and related diseases in the future [134] (Figure 11). The gene discussed is NTN1; the disease is idiopathic pulmonary fibrosis.